SERA
Sera Prognostics (SERA)
$52
About Sera Prognostics (SERA)
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Details
Daily high
$2.68
Daily low
$2.35
Price at open
$2.35
52 Week High
$4.64
52 Week Low
$1.37
Market cap
97.3M
Dividend yield
0.00%
Volume
28,732
Avg. volume
44,597
P/E ratio
-3.27
Sera Prognostics News
Details
Daily high
$2.68
Daily low
$2.35
Price at open
$2.35
52 Week High
$4.64
52 Week Low
$1.37
Market cap
97.3M
Dividend yield
0.00%
Volume
28,732
Avg. volume
44,597
P/E ratio
-3.27